(Boursier.com) — The biopharmaceutical company Aelis Farma made, on September 27, an additional contribution of €100k in cash to the resources allocated to the liquidity contract signed on December 27, 2022 with Invest Securities. This increase aims to rebalance the allocated resources, ensure better liquidity for the stock and, where applicable, avoid price shifts not justified by the market trend.
After taking this contribution into account, the resources allocated to the liquidity contract as of September 27, 2023 post-market closing were 67,250 securities and 15,347.88 euros in cash.
©2023 Boursier.com